miRNA | Relative Expression | Malignancy | miRNA | Relative Expression | Malignancy |
---|---|---|---|---|---|
Downregulated NTera2 | Downregulated 2102Ep | ||||
 |  |  |  |  | Tumourigenesis [63] |
miR-507 | -100,000 | Â | miR-518c* | -634.0 | Â |
miR-142-5p | -100,000 | Lung [64] | miR-153 | -30.9 | Â |
 |  |  |  |  | Lung [77] |
miR-520b | -100,000 | Â | let-7g | -10.1 | Colon [78] |
miR-522 | -100,000 | Â | miR-504 | -9.9 | Â |
miR-122a | -100,000 | Â | miR-362 | -8.1 | Â |
 |  |  |  |  | Lymphoma [52] |
miR-515-5p | -100,000 | Â | miR-17-3p | -6.2 | Colorectal [62] |
miR-182* | -100,000 | Prostate [65] | miR-511 | -3.4 | Liver [47] |
miR-199a* | -100,000 | Lung [66] | miR-193b | -3.2 | Endometrial [72] |
 |  | Mesothelioma [67] |  |  |  |
miR-7 | -100,000 | Lung & Breast [68] | miR-455 | -2.8 | Â |
miR-206 | -100,000 | Breast [69] | miR-431 | -2.7 | Â |
Upregulated NTera2 | Upregulated 2102Ep | ||||
 |  | Kaposi Sarcoma [70] |  |  | Medullablastoma [79] |
miR-140 | 6.1 | Breast [30] | miR-199b | 2.6 | Â |
 |  | Breast [59] |  |  | Lymphoma [80] |
miR-191* | 6.7 | Leukaemia [51] | miR-363 | 2.6 | Â |
miR-188 | 8.3 | Â | miR-129 | 3.0 | Gastric [81] |
 |  | Endometrial [71] |  |  | Tongue [78] |
miR-99b | 11.1 | Â | miR-184 | 3.8 | Neural [82] |
miR-509 | 18.3 | Â | miR-519d | 3.8 | Â |
 |  | Tongue [72] |  |  | Breast [75] |
miR-219 | 21.9 | Â | miR-10a | 119.2 | Leukaemia [83] |
 |  | Lung [73] |  |  |  |
miR-99a | 22.5 | Ovary [35] | miR-433 | 100000 | Â |
 |  | Ovary [61] |  |  | Glioblastoma [84] |
miR-335 | 26.0 | Myeloma [74] | miR-425 | 100000 | Â |
 |  | Breast [75] |  |  | Multiple [85] |
miR-10a | 100000 | Leukaemia [51] | miR-105 | 100000 | Â |
 |  | Prostate [76] |  |  | Glioblastoma [86] |
let-7c | 100000 | Lung [52] | miR-137 | 100000 | Melanoma [87] |